The active component in this medication is Gliclazide. It is a short-acting sulfonylurea compound with hypoglycemic activity. It increases peripheral insulin sensitivity metabolized by CYP2C9. It is an antihyperglycemic agent useful for the treatment of non-insulin-dependent diabetes mellitus.
It increases both basal insulin secretion and meal-stimulated insulin release. It acts by decreasing hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors.
This active component of Diamicron is indicated for the control of blood glucose in people with type 2 diabetes. It must be used in conjunction with diet and exercise regimens to control high blood sugar in non-insulin-dependent diabetics. Managing high blood sugar prevents heart disease, strokes, kidney disease, circulation problems, and blindness.
This medication belongs to a class of medicines called oral hypoglycemics. It is approved for the control of blood glucose in people with type 2 diabetes. It should be taken when diet, exercise, and weight reduction have not been found to control blood glucose properly. Diamicron increases the amount of insulin released by the pancreas and helps the body use insulin.
- Decreased Heartbeat
- Stomach Pain
- Skin Rash
- Low Blood Sugar Levels
This medication is made available in dosages as mentioned below:
- 40 mg: This tablet should be taken exactly as mentioned in the prescription by the doctor.
- 80 mg: It is to be consumed as mentioned in the prescription by the doctor, do not go against it.
This medication is contraindicated in people with type 1 diabetes and unstable diabetes or ketoacidosis.